Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: Illustrations from Lebanon

American Journal of Public Health

Volumn 99, Issue 9, 2009, Pages 1562-1567

  DeJong, Jocelyn ^b   Mahfoud, Ziyad ^b   Khoury, Danielle ^b   Barbir, Farah ^b   Afifi, Rema Adel ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG USE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFORMED CONSENT; LEBANON; MALE HOMOSEXUAL; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL RESEARCH; REVIEW; STIGMA;

DATA COLLECTION; DEVELOPING COUNTRIES; DRUG USERS; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INFORMED CONSENT; LEBANON; MALE; PROSTITUTION; RESEARCH DESIGN; SAMPLING STUDIES;

EID: 69049104231     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.144832     Document Type: Review

References (28)

1. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174-199.
2. Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49:11-34.
3. Heckathorn DD. Cornell University. Respondent driven sampling. Available at: http://www.respondentdrivensampling.org. Accessed June 2, 2008.
4. Heckathorn DD, Semaan S, Broadhead RS, Hughes JJ. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav. 2002;6(1):55-67.
5. Semaan S, Santibanez S, Garfein RS, Heckathorn DD, Des Jarlais DC. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy. 2009;20(1):14-27.
6. Heimer R. Critical issues and further questions about respondent-driven sampling: comment on Ramirez-Valles, et al. (2005). AIDS Behav. 2005;9:403-408.
7. Ramirez-Valles J, Heckathorn DD, Vázquez R, Diaz RM, Campbell RT. The fit between theory and data in respondent-driven sampling: response to Heimer. AIDS Behav. 2005;9:409-414.
8. Simic M, Johnston LG, Platt L, et al. Exploring barriers to respondent driven sampling in sex worker and drug-injecting sex worker populations in Eastern Europe. J Urban Health. 2006;83(suppl 6):i6-i15.
9. Johnston LG, Sabin K, Mai TH, Pham TH. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: researching the unseen sex worker. J Urban Health. 2006;83(suppl 6):i16-i28.
10. Platt L, Wall M, Rhodes T, et al. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health. 2006;83(suppl 6):i39-i53.
11. Yeka W, Maibani-Michie G, Prybylski D, Colby D. Application of respondent driven sampling to collect baseline data on FSWs and MSM for HIV risk reduction interventions in two urban centres in Papua New Guinea. J Urban Health. 2006;83(suppl 6):i60-i72.
12. Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(suppl 4):S105-S130.
13. Scott G. They got their program, and I got mine: a cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. Int J Drug Policy. 2008;19:42-51.
14. Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008;12(suppl4):S131-S141.
15. Broadhead RS. Notes on a cautionary (tall) tale about respondent-driven sampling: a critique of Scott's ethnography. Int J Drug Policy. 2008;19:235-237.
16. Lansky A, Maestro T. Using respondent-driven sampling for behavioural surveillance: response to Scott. Int J Drug Policy. 2008;19:241-243.
17. Ouellet LJ. Cautionary comments on an ethnographic tale gone wrong. Int J Drug Policy. 2008;19:238-240.
18. Prachand NG, Benbow N. Clarifying the ethnographer's role in Chicago's HIV behavioural surveillance - injecting drug users cycle, 2005: response to Scott. Int J Drug Policy. 2008;19:244-245.
19. UNAIDS, World Health Organization. 2007 AIDS epidemic update. Available at: http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf. Accessed June 2, 2008.
20. Latest HIV statistics in Lebanon [press release]. Beirut, Lebanon: National AIDS Program in Lebanon; December 19, 2008.
21. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm. Accessed June 1, 2008.
22. Fry CL, Hall W, Ritter A, Jenkinson R. The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics. 2006;1:21-36.
23. Fry C, Dwyer R. For love or money? An exploratory study of why injecting drug users participate in research. Addiction. 2001;96:1319-1325.
24. Bentley JP, Thacker PG. The influence of risk and monetary payment on the research participation decision making process. JMed Ethics. 2004;30:293-298.
25. Grady C. Money for research participation: does it jeopardize informed consent? Am J Bioeth. 2001;1:40-44.
26. Ritter AJ, Fry CL, Swan A. The ethics of reimbursing injecting drug users for public health research interviews: what price are we prepared to pay? Int J Drug Policy. 2003;14:1-3.
27. Festinger DS, Marlowe DB, Croft JR, et al. Do research payments precipitate drug use or coerce participation? Drug Alcohol Depend. 2005;78:275-281.
28. Seddon T. Paying drug users to take part in research: justice, human rights and business perspectives on the use of incentive payments. Addict Res Theory. 2005;13:101-109.